|
1
|
Wuyts WA, Agostini C, Antoniou KM, Bouros
D, Chambers RC, Cottin V, Egan JJ, Lambrecht BN, Lories R, Parfrey
H, et al: The pathogenesis of pulmonary fibrosis: a moving target.
Eur Respir J. 41:1207–1218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raghu G, Collard HR, Egan JJ, Martinez FJ,
Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et
al: ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An
official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:
evidence-based guidelines for diagnosis and management. Am J Respir
Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raghu G, Weycker D, Edelsberg J, Bradford
WZ and Oster G: Incidence and prevalence of idiopathic pulmonary
fibrosis. Am J Respir Crit Care Med. 174:810–816. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiss DJ, Bertoncello I, Borok Z, Kim C,
Panoskaltsis-Mortari A, Reynolds S, Rojas M, Stripp B, Warburton D
and Prockop DJ: Stem cells and cell therapies in lung biology and
lung diseases. Proc Am Thorac Soc. 8:223–272. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bailey MM, Wang L, Bode CJ, Mitchell KE
and Detamore MS: A comparison of human umbilical cord matrix stem
cells and temporomandibular joint condylar chondrocytes for tissue
engineering temporomandibular joint condylar cartilage. Tissue Eng.
13:2003–2010. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Conconi MT, Burra P, Di Liddo R, Calore C,
Turetta M, Bellini S, Bo P, Nussdorfer GG and Parnigotto PP:
CD105(+) cells from Wharton's jelly show in vitro and in
vivo myogenic differentiative potential. Int J Mol Med.
18:1089–1096. 2006.PubMed/NCBI
|
|
7
|
Lindenmair A, Hatlapatka T, Kollwig G,
Hennerbichler S, Gabriel C, Wolbank S, Redl H and Kasper C:
Mesenchymal stem or stromal cells from amnion and umbilical cord
tissue and their potential for clinical applications. Cells.
1:1061–1088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Avanzini MA, Bernardo ME, Cometa AM,
Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C,
Villa R, et al: Generation of mesenchymal stromal cells in the
presence of platelet lysate: a phenotypic and functional comparison
of umbilical cord blood- and bone marrow-derived progenitors.
Haematologica. 94:1649–1660. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Divya MS, Roshin GE, Divya TS, Rasheed VA,
Santhoshkumar TR, Elizabeth KE, James J and Pillai RM: Umbilical
cord blood-derived mesenchymal stem cells consist of a unique
population of progenitors co-expressing mesenchymal stem cell and
neuronal markers capable of instantaneous neuronal differentiation.
Stem Cell Res Ther. 3:572012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu Z, Guo S, Fang G, Cui Z and Liu Y: AKT
pathway affects bone regeneration in nonunion treated with
umbilical cord-derived mesenchymal stem cells. Cell Biochem
Biophys. 71:1543–1551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Z, Guo L, Fang G, Cui Z, Guo S and Liu
Y: Biological characteristics and effect of human umbilical cord
mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on
bone regeneration in rats. Cell Biochem Biophys. 63:171–181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu Z, Fang G, Cui Z and Liu Y: Cell
therapy for bone nonunion: a retrospective study. Minerva Med.
106:315–321. 2015.PubMed/NCBI
|
|
13
|
Tzouvelekis A, Paspaliaris V, Koliakos G,
Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N,
Dardzinski B, Gritzalis D, et al: A prospective, non-randomized, no
placebo-controlled, phase Ib clinical trial to study the safety of
the adipose derived stromal cells-stromal vascular fraction in
idiopathic pulmonary fibrosis. J Transl Med. 11:1712013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Shi ZL and Zhao Z: Transplantation
of human umbilical cord-derived mesenchymal stem cells improves
hepatic fibrosis in rats with carbon etrachloride-induced hepatic
cirrhosis. Chinese Tissue Engineering Res. 16:1837–1840. 2012.(In
Chinese). http://d.g.wanfangdata.com.cn/Periodical_xdkf201210028.aspx
|
|
15
|
Ortiz LA, Dutreil M, Fattman C, Pandey AC,
Torres G, Go K and Phinney DG: Interleukin 1 receptor antagonist
mediates the antiinflammatory and antifibrotic effect of
mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA.
104:11002–11007. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chambers DC, Enever D, Ilic N, Sparks L,
Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM and
Hopkins PM: A phase 1b study of placenta-derived mesenchymal
stromal cells in patients with idiopathic pulmonary fibrosis.
Respirology. 19:1013–1018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiss DJ, Casaburi R, Flannery R,
LeRoux-Williams M and Tashkin DP: A placebo-controlled, randomized
trial of mesenchymal stem cells in COPD. Chest. 143:1590–1598.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toonkel RL, Hare JM, Matthay MA and
Glassberg MK: Potential for Clinical Testing: Mesenchymal stem
cells and idiopathic pulmonary fibrosis. Potential for clinical
testing. Am J Respir Crit Care Med. 188:133–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
